AU2011262606B2 - Trisaccharide derivates, and their use as adjuvants - Google Patents

Trisaccharide derivates, and their use as adjuvants Download PDF

Info

Publication number
AU2011262606B2
AU2011262606B2 AU2011262606A AU2011262606A AU2011262606B2 AU 2011262606 B2 AU2011262606 B2 AU 2011262606B2 AU 2011262606 A AU2011262606 A AU 2011262606A AU 2011262606 A AU2011262606 A AU 2011262606A AU 2011262606 B2 AU2011262606 B2 AU 2011262606B2
Authority
AU
Australia
Prior art keywords
trisaccharide
fatty acid
derivate
acid
raffinose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2011262606A
Other languages
English (en)
Other versions
AU2011262606A1 (en
Inventor
Robert Patrick Hof
Maria Aldegonda Jacoba Kriek
Wilhelmus Martinus Maria Schaaper
Everardus Joannes Peter Maria Schenkelaars
Jouwert Anne Turkstra
Johannes Gernardus Mathias Marie Van Bree
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunovo BV
Original Assignee
Immunovo BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunovo BV filed Critical Immunovo BV
Publication of AU2011262606A1 publication Critical patent/AU2011262606A1/en
Application granted granted Critical
Publication of AU2011262606B2 publication Critical patent/AU2011262606B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
AU2011262606A 2010-06-11 2011-06-03 Trisaccharide derivates, and their use as adjuvants Ceased AU2011262606B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10165707A EP2397484A1 (en) 2010-06-11 2010-06-11 Trisaccharide derivates, and their use as adjuvants
EP10165707.0 2010-06-11
PCT/NL2011/050393 WO2011155822A1 (en) 2010-06-11 2011-06-03 Trisaccharide derivates, and their use as adjuvants

Publications (2)

Publication Number Publication Date
AU2011262606A1 AU2011262606A1 (en) 2013-01-10
AU2011262606B2 true AU2011262606B2 (en) 2016-10-27

Family

ID=43734127

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011262606A Ceased AU2011262606B2 (en) 2010-06-11 2011-06-03 Trisaccharide derivates, and their use as adjuvants

Country Status (25)

Country Link
US (2) US9327020B2 (enExample)
EP (3) EP2397484A1 (enExample)
JP (2) JP6004586B2 (enExample)
KR (1) KR101929973B1 (enExample)
CN (1) CN103154013B (enExample)
AU (1) AU2011262606B2 (enExample)
BR (1) BR112012031440A2 (enExample)
CA (1) CA2802023C (enExample)
CY (1) CY1119704T1 (enExample)
DK (1) DK2580226T3 (enExample)
ES (1) ES2654156T3 (enExample)
HR (1) HRP20171947T1 (enExample)
HU (1) HUE035187T2 (enExample)
IL (1) IL223570A (enExample)
LT (1) LT2580226T (enExample)
MX (1) MX342946B (enExample)
NO (1) NO2580226T3 (enExample)
PL (1) PL2580226T3 (enExample)
PT (1) PT2580226T (enExample)
RS (1) RS56690B1 (enExample)
RU (1) RU2595717C2 (enExample)
SI (1) SI2580226T1 (enExample)
SM (1) SMT201700603T1 (enExample)
WO (1) WO2011155822A1 (enExample)
ZA (1) ZA201209395B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants
NZ728551A (en) * 2014-07-24 2023-02-24 Litevax B V Sulphated carbohydrate fatty acid esters as vaccine adjuvants
KR102922337B1 (ko) 2023-10-11 2026-02-05 세종대학교산학협력단 삼당류의 제조방법

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232150A (en) * 1979-07-09 1980-11-04 American Cyanamid Company Oligosaccharide precursors to substituted O-α-D and O-β-D-multigalactopyranosyl and glucopyranosyl 1→4 and 1→6 galactopyranosyl 1→6α-D-glucopyranoses
EP1792607A1 (en) * 2005-12-01 2007-06-06 Wella Aktiengesellschaft Use of di- or oligosaccharide polyester in hair styling products
US20090042816A1 (en) * 2007-04-16 2009-02-12 Suri Saranathan Iyer Synthetic Ligands For The Differentiation Of Closely Related Toxins And Pathogens

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8703128D0 (en) * 1987-02-11 1987-03-18 Donmarn Ltd Anti-scaling compounds
US5543505A (en) * 1993-03-15 1996-08-06 Sloan-Kettering Institute For Cancer Research Synthetic compounds which bind to H. pylori, and uses thereof
US5708163A (en) * 1994-03-15 1998-01-13 Sloan-Kettering Institute Of Cancer Research Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof
US6303120B1 (en) * 1994-03-15 2001-10-16 Memorial Sloan-Kettering Institute For Cancer Research Synthesis of glycoconjugates of the lewis y epitope and uses thereof
ATE252373T1 (de) * 1994-08-04 2003-11-15 Elan Drug Delivery Ltd Feste verabreichungssysteme zur gesteuerten freisetzung von darin eingebauten molekülen sowie verfahren zu deren herstellung
BE1008978A5 (fr) 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
ZA9711732B (en) * 1996-12-31 1998-12-28 Quadrant Holdings Cambridge Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
JP3041799B1 (ja) * 1998-09-29 2000-05-15 株式会社微生物化学研究所 新規なアジュバント及びそれを用いたワクチン
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
GB0124710D0 (en) * 2001-10-15 2001-12-05 Quadrant Healthcare Uk Ltd Therapeutic composition
WO2009140683A1 (en) * 2008-05-16 2009-11-19 Research Foundation Of The City University Of New York Living copolymer protein/peptide hybrids for biomedical applications
US8993536B2 (en) * 2009-02-02 2015-03-31 Otsuka Chemical Co., Ltd. Low-molecular polysulfated hyaluronic acid derivative and medicine containing same
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232150A (en) * 1979-07-09 1980-11-04 American Cyanamid Company Oligosaccharide precursors to substituted O-α-D and O-β-D-multigalactopyranosyl and glucopyranosyl 1→4 and 1→6 galactopyranosyl 1→6α-D-glucopyranoses
EP1792607A1 (en) * 2005-12-01 2007-06-06 Wella Aktiengesellschaft Use of di- or oligosaccharide polyester in hair styling products
US20090042816A1 (en) * 2007-04-16 2009-02-12 Suri Saranathan Iyer Synthetic Ligands For The Differentiation Of Closely Related Toxins And Pathogens

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
: YAO, Q. ET AL.: "Chemoenzymatic synthesis of iGb3 and Gb3", ORGANIC LETTERS, vol. 8, no. 6, 2006, pages 911-914, *
AKOH, C.C. AND SWANSON, B.G.: "One stage synthesis of raffinose fatty acid polyesters", JOURNAL OF FOOD SCIENCE, vol. 52, no. 6, 1987, pages 1570-1576 *
ARNDT PET AL: "Preparation of Cellulose Oligomers from Cellulose Triacetate (Standard Procedure)", CELLULOSE, KLUWER ACADEMIC PUBLISHERS, DO, vol. 12, no. 3, 1 June 2005, pages 317-326, *
MOGEMARK, M. ET AL.: ORGANIC & BIOMOLECULAR CHEMISTRY, vol. 1, 2003, pages 2063-2069, *

Also Published As

Publication number Publication date
IL223570A (en) 2017-03-30
JP2016216471A (ja) 2016-12-22
MX342946B (es) 2016-10-18
JP6004586B2 (ja) 2016-10-12
DK2580226T3 (en) 2018-01-08
CA2802023C (en) 2020-07-14
CA2802023A1 (en) 2011-12-15
RU2013100945A (ru) 2014-07-20
BR112012031440A2 (pt) 2017-04-18
RS56690B1 (sr) 2018-03-30
SMT201700603T1 (it) 2018-03-08
EP2580226B1 (en) 2017-11-29
HRP20171947T1 (hr) 2018-02-23
NO2580226T3 (enExample) 2018-04-28
US20130273082A1 (en) 2013-10-17
MX2012014422A (es) 2013-08-27
LT2580226T (lt) 2018-02-26
HUE035187T2 (hu) 2018-05-02
WO2011155822A1 (en) 2011-12-15
PL2580226T3 (pl) 2018-05-30
US20170057987A1 (en) 2017-03-02
EP2580226A1 (en) 2013-04-17
KR20130056273A (ko) 2013-05-29
JP2013528211A (ja) 2013-07-08
EP3312188A1 (en) 2018-04-25
ES2654156T3 (es) 2018-02-12
CY1119704T1 (el) 2018-06-27
US9327020B2 (en) 2016-05-03
CN103154013A (zh) 2013-06-12
EP2397484A1 (en) 2011-12-21
AU2011262606A1 (en) 2013-01-10
SI2580226T1 (en) 2018-04-30
KR101929973B1 (ko) 2018-12-18
ZA201209395B (en) 2014-05-28
RU2595717C2 (ru) 2016-08-27
CN103154013B (zh) 2017-03-15
PT2580226T (pt) 2018-01-05

Similar Documents

Publication Publication Date Title
Rudra et al. Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope
JP5025869B2 (ja) 単糖および二糖誘導体
US20080187553A1 (en) Immunstimulating lipid formulation
FR2598622A1 (fr) Adjuvants immunologiques pour vaccins polysaccharidiques
JP2002534480A (ja) 改良サポニンアジュバント組成物およびそれに関する方法
PT988862E (pt) Formulação compreendendo um antigénio, um adjuvante indutor de th-1 e um aminoácido pouco solúvel em água, para utilização em imunização
Blom et al. Sucrose fatty acid sulphate esters as novel vaccine adjuvants: effect of the chemical composition
US20170057987A1 (en) Trisaccharide Derivates, and Their Use as Adjuvants
AU2015294769B2 (en) Adjuvants
RU2712750C1 (ru) Амилоидный конъюгат, его применения и способы
CA2954043C (en) Carbohydrate ester adjuvants
JP2025532430A (ja) テルペノイドおよび高分子を含む新規な組成物、ならびにその使用
JP2000504350A (ja) キトサン誘導性免疫強化
BR112018016016B1 (pt) Composição farmacêutica compreendendo um conjugado de um ou mais peptídeos cysab (33-40) (seq id no: 1) ligado à hemocianina do molusco keyhole limpet (klh), seu uso, seu método de produção, e ampola de vidro

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired